Skip to main content
. 2025 Nov 7;17(22):3602. doi: 10.3390/cancers17223602
EC Endometrial Cancer
AUB Abnormal Uterine Bleeding
TH/BSO Total hysterectomy with bilateral salpingo-oophorectomy
TCGA The Cancer Genome Atlas
ProMisE Proactive Molecular Risk Classifier for endometrial cancer
LVSI Lymphovascular space invasion
D&C dilation and curettage
MRI Magnetic Resonance Imaging
TVUS Transvaginal ultrasound
LNG-IUD Norgestrel-Releasing Intrauterine Device
ECOG Eastern Cooperative Oncology Group
CR Complete response rate
RR Recurrence rate
PR Pregnancy rate
LBR Live birth rate
ART Assisted Reproductive Technology
MSI microsatellite instability
CN-L copy-number low
CN-H copy-number high
POLE-mut POLE-mutated
MMRd mismatch repair deficient
p53-abn p53 Abnormality
NSMP non-specific molecular profile
IHC immunohistochemistry
POLE polymerase epsilon
EDM exonuclease domains
FIGO International Federation of Gynecology and Obstetrics
EEC endometrioid carcinoma
MSI-high Microsatellite instability-High
MMR Mismatch repair
ESMO European Society for Medical Oncology
PCR-based molecular Polymerase Chain Reaction-based
ER Estrogen Receptor
PR Progesterone Receptor
PORTEC Post Operative Radiation Therapy in Endometrial Carcinoma
NGS Next-Generation Sequencing
LNG-IUS Levonorgestrel-releasing Intrauterine System
ESGO European Society of Gynaecological Oncology
ESTRO European Society for Radiotherapy and Oncology
ESP European Society of Pathology
NCCN National Comprehensive Cancer Network
RCT Randomized Controlled Trial
AI Artificial Intelligence